Search research articles
Contact Us
Filters
Showing results (21-30 of 719) with videos related to
Page
of 72
Sort By:
Frontiers in Pharmacology
|
June 14, 2024
Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis
Emiko Otsuka, Mineaki Kitamura, Satoshi Funakoshi, et al.
Renal Failure
|
October 8, 2024
Roxadustat has risks of reversible central hypothyroidism in patients undergoing hemodialysis: a single-center retrospective cohort study
Emiko Otsuka, Mineaki Kitamura, Satoshi Funakoshi, et al.
Respiration; International Review of Thoracic Diseases
|
December 11, 2003
Acute respiratory distress syndrome induced by rifampicin with high levels of neutrophil and eosinophil products in bronchoalveolar lavage fluid
Jun-Ichi Ashitani, Shigehisa Yanagi, Yasuji Arimura, et al.
Inhalation Toxicology
|
October 5, 2011
Foam cell formation of alveolar macrophages in Clara cell ablated mice inhaling crystalline silica
Kazuhiro Yatera, Yasuo Morimoto, Heung-Nam Kim, et al.
International Journal of Antimicrobial Agents
|
November 24, 2004
Efficacy of long-term macrolide antibiotic therapy in patients with diffuse panbronchiolitis: comparison between HLA-B54-positive and -negative cases
Jun-ichi Kadota, Hiroshi Mukae, Kazunori Tomono, et al.
International Archives of Allergy and Immunology
|
March 28, 2003
Critical role of IL-5 in antigen-induced pulmonary eosinophilia, but not in lymphocyte activation
Nobuhiro Matsumoto, Shigeki Katoh, Hiroshi Mukae, et al.
The Japanese Journal of Antibiotics
|
August 23, 2016
[New therapeutic strategies for pulmonary infection: the potency of immune activation by macrolides and Toll-like receptor agonist]
Shigeki Nakamura, Koichi Izumikawa, Katsunori Yanagihara, et al.
Respiratory Investigation
|
September 26, 2024
Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis
Natsuki Nakagawa, Masashi Ito, Takanori Asakura, et al.
Chest
|
August 7, 2010
A higher significance of anaerobes: the clone library analysis of bacterial pleurisy
Toshinori Kawanami, Kazumasa Fukuda, Kazuhiro Yatera, et al.
Respirology (Carlton, Vic.)
|
April 23, 2010
Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
Ryo Kozu, Sue Jenkins, Hideaki Senjyu, et al.
Page
of 72
Search research articles
Search
Showing results (21-30 of 719) with videos related to
Sort By:
Page
of 72
Frontiers in Pharmacology
|
June 14, 2024
Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis
Emiko Otsuka, Mineaki Kitamura, Satoshi Funakoshi, et al.
Renal Failure
|
October 8, 2024
Roxadustat has risks of reversible central hypothyroidism in patients undergoing hemodialysis: a single-center retrospective cohort study
Emiko Otsuka, Mineaki Kitamura, Satoshi Funakoshi, et al.
Respiration; International Review of Thoracic Diseases
|
December 11, 2003
Acute respiratory distress syndrome induced by rifampicin with high levels of neutrophil and eosinophil products in bronchoalveolar lavage fluid
Jun-Ichi Ashitani, Shigehisa Yanagi, Yasuji Arimura, et al.
Inhalation Toxicology
|
October 5, 2011
Foam cell formation of alveolar macrophages in Clara cell ablated mice inhaling crystalline silica
Kazuhiro Yatera, Yasuo Morimoto, Heung-Nam Kim, et al.
International Journal of Antimicrobial Agents
|
November 24, 2004
Efficacy of long-term macrolide antibiotic therapy in patients with diffuse panbronchiolitis: comparison between HLA-B54-positive and -negative cases
Jun-ichi Kadota, Hiroshi Mukae, Kazunori Tomono, et al.
International Archives of Allergy and Immunology
|
March 28, 2003
Critical role of IL-5 in antigen-induced pulmonary eosinophilia, but not in lymphocyte activation
Nobuhiro Matsumoto, Shigeki Katoh, Hiroshi Mukae, et al.
The Japanese Journal of Antibiotics
|
August 23, 2016
[New therapeutic strategies for pulmonary infection: the potency of immune activation by macrolides and Toll-like receptor agonist]
Shigeki Nakamura, Koichi Izumikawa, Katsunori Yanagihara, et al.
Respiratory Investigation
|
September 26, 2024
Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis
Natsuki Nakagawa, Masashi Ito, Takanori Asakura, et al.
Chest
|
August 7, 2010
A higher significance of anaerobes: the clone library analysis of bacterial pleurisy
Toshinori Kawanami, Kazumasa Fukuda, Kazuhiro Yatera, et al.
Respirology (Carlton, Vic.)
|
April 23, 2010
Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
Ryo Kozu, Sue Jenkins, Hideaki Senjyu, et al.
Page
of 72